Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Femeda is a UK-based medical technology company specializing in innovative solutions for women's pelvic health. The company's flagship product, Pelviva, is a pioneering, disposable medical device designed to treat urinary incontinence using neuromuscular electrical stimulation (NMES). Pelviva is unique as it is a self-contained, discreet, and easy-to-use device that automates pelvic floor muscle exercises, effectively mimicking Kegel exercises. By delivering targeted electrical pulses, the device helps to strengthen the pelvic floor muscles, addressing stress, urge, and mixed urinary incontinence. Femeda aims to improve the quality of life for millions of women worldwide by providing an effective, non-surgical treatment option that can be used in the privacy of one's home.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Femeda.